Vasculitis Clinical Research Consortium

$1,250,000U54FY2009ARNIH

Boston University Medical Campus, Boston MA

Investigators

Linked publications & trials

Paper 39153834 Paper 39010674 Paper 38343337 Paper 38025219 Paper 37625669 Paper 37433067 Paper 36958796 Paper 36917158 Paper 36878421 Paper 36797040 Paper 36440847 Paper 35768848 Paper 35612893 Paper 35136992 Paper 34792864 Paper 34730828 Paper 34521663 Paper 34032390 Paper 33882989 Paper 33717128 Paper 33521671 Paper 33308445 Paper 33202101 Paper 33060304 Paper 32602262 Paper 32581088 Paper 32460147 Paper 32459634 Paper 32345372 Paper 32169041 Paper 32053298 Paper 31580452 Paper 31474593 Paper 31444857 Paper 31375256 Paper 31199488 Paper 31162829 Paper 31121115 Paper 31025933 Paper 30877212 Paper 30877209 Paper 30824648 Paper 30795559 Paper 30709951 Paper 30678705 Paper 30652675 Paper 30352204 Paper 30308057 Paper 29953750 Paper 29880442 Paper 29724730 Paper 29695498 Paper 29693324 Paper 29666047 Paper 29470262 Paper 29379322 Paper 29352849 Paper 29145713 Paper 29124398 Paper 29112740 Paper 28980910 Paper 28864650 Paper 28864648 Paper 28864646 Paper 28765246 Paper 28277489 Paper 28270229 Paper 28246067 Paper 28133931 Paper 28133925 Paper 28029757 Paper 27876769 Paper 27804171 Paper 27438345 Paper 27259977 Paper 27194034 Paper 27036388 Paper 26914103 Paper 26586608 Paper 26373563 Paper 26329344 Paper 26315859 Paper 26077399 Paper 26016754 Paper 25939343 Paper 25934819 Paper 25877501 Paper 25875256 Paper 25817017 Paper 25812008 Paper 25604533 Paper 25406357 Paper 25048363 Paper 24634202 Paper 24625507 Paper 24488418 Paper 24429177 Paper 24323392 Paper 24257367 Paper 23908447

Abstract

DESCRIPTION (provided by applicant): The Vasculitis Clinical Research Consortium (VCRC) was established in 2003 and in 5 years of rapid growth and productivity has become the major clinical research infrastructure in North America dedicated to the study of vasculitis. The VCRC is a founding member and leading force of the NIH Rare Diseases Clinical Research Network (RDCRN). By conducting a series of longitudinal cohort studies, biomarker discovery projects, multicenter clinical trials, and outcome measure development projects, the Consortium is addressing serious unmet medical and scientific needs for this group of complex rare diseases. The VCRC currently has over 500 patients in clinical research on the following 6 types of vasculitis: giant cell arteritis, Takayasu's arteritis, polyarteritis nodosa, Wegener's granulomatosis, microscopic polyangiitis, and Churg Straus Syndrome. Each of these diseases are consider "orphan" diseases. Additionally, partnership with patient advocacy groups has been a critical component to the success of the VCRC. The VCRC electronic resources are important for patients worldwide. The VCRC Fellowship Program has successfully trained new clinical investigators, each of whom remains engaged in academic research in vasculitis. This proposal outlines a total of 13 separate clinical protocols with 10 associated studies of biomarkers VCRC investigators have successfully obtained ancillary funding to allow for expansion of the Consortium's work. Sources of these funds include the NIH, the FDA, private foundation and the biopharmaceutical industry. This application seeks refunding of the VCRC to both support the critical administrative, laboratory, biostatistical cores and allow completion of ongoing projects, launch of exciting new scientific initiatives training of new investigators in clinical research in vasculitis, and expansio n of the VCRC website.

View original record on NIH RePORTER →